Rongchang Biological: Successfully issued and distributed 19 million new H shares at a price of HK$42.44 per share.

Rongchang biology announced that on May 29, 2025, the company successfully issued a total of 19 million new H shares to no fewer than six underwriters at a subscription price of HK$42.44 per share, accounting for approximately 9.11% of the total number of issued H shares after the issuance and approximately 3.37% of the total number of issued shares. The total amount raised from the subscription is approximately HK$806.36 million, and the net amount received by the company from the subscription is approximately HK$796 million.